A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Impax Asset Management 28 May 2021

Surging AUM boosts revenue, profit & dividend

AUM reached £30.0bn on 31 Mar 21, up 49% over H1 (£20.2bn on 30 Sep 2020). Net inflows were...

Read more
Strix Group 27 May 2021

Upgrades highlight group’s undervaluation

The trading update ahead of the AGM was positive, highlighting the ongoing recovery in Kettle...

Read more
Benchmark Holdings 25 May 2021

Growth drivers aligned with aquaculture sustainability goals

BMK reported solid H1 2021 progress in line with expectations. 11% (Constant Exchange Rates)...

Read more
Gattaca 21 May 2021

Upgrading FY21 forecasts & valuation to 280p/share

A ‘V-shaped’ recovery, together with a shortage of qualified staff, is providing a favourable...

Read more
Begbies Traynor 20 May 2021

‘Comfortably ahead of market expectations’

We have upgraded our FY21e forecasts in line with the year-end trading update, which confirmed an...

Read more
Kromek Group 11 May 2021

Est H2’21 sales (£5.4m) jump 17% vs H1’21 (£4.6m)

After a quiet H1 due to the pandemic, Kromek is now enjoying a powerful rebound for its next...

Read more
Begbies Traynor 11 May 2021

Latest deal enhances revenues and relationships

The latest acquisition, Midlands based finance broker MAF Property Limited (trades as MAF Finance...

Read more
RUA Life Sciences 10 May 2021

Direction of travel intact

Ahead of its FY 2021 results in July, RUA Life Sciences’ trading update included its first year...

Read more
Destiny Pharma 04 May 2021

M3: another gem in the portfolio

With the recent announcement of the positive Phase 2b clinical study of XF-73 in the prevention of...

Read more

Register to be first

Get research on the companies that interest you straight to your inbox

Register For Updates